PSA vs VXRT · rev $4.82B vs rev $28.7M
PSA (PSA) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
PSA currently screens at market cap $0. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the PSA and VXRT stock pages for the full models.
Not investment advice.